Best immunologists in Israel: TOP 16 doctors

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Katsman specializes in HIV care at Sourasky Medical Center, with over 26 years of experience of experience in infectious diseases.

• Senior staff physician at Tel Aviv Sourasky Medical Center
• Advanced training at McGill AIDS Centre in Montreal
• Member of International AIDS Society and European AIDS Clinical Society
• Affiliated with The Crusaid Kobler AIDS Center

Dr. Grisaro Galia leads the Pediatric Infectious Diseases service at Dana-Dwek Children's Hospital – specializing exclusively in pediatric cases.

• Director-level role at a top children's hospital
• Trained at University of Toronto – a global leader in infectious disease research
• Holds a Marze Bachir degree in pediatric infectious diseases
• Focuses on complex pediatric infectious cases

Professor Eli Sprecher leads the Dermatology Department at Tel Aviv's Sourasky Medical Center, with a focus on genetic skin diseases.

• Specialized in dermatological genetics at Thomas Jefferson University
• Authored over 220 scientific publications in dermatology
• Member of key societies including the American Academy of Dermatology
• Professorship at Technion – Israel Institute of Technology

Head of rheumatology at Sourasky Medical Center – Dr. Kaspy specializes in complex cases and leads Israel's rheumatology specialization programs.

• Completed prestigious internship at Hammersmith Hospital in London
• Former Head of the day hospital in rheumatology at Ichilov
• 140+ scientific publications on rheumatology
• Member of both Israeli and American Rheumatology Associations

Featured in Forbes' 2021 list of Israel's top physicians, Prof. Kivity specializes in allergy and immunology at Sourasky Medical Center.

• Expert in diagnosing and treating allergies, asthma, and allergic rhinitis
• Member of multiple international allergy and immunology societies
• Trained at prestigious institutions including National Jewish Hospital
• Recipient of multiple research awards in immunology

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

Leading the Hematology Department at Hadassah Medical Center, Prof. Dina Ben-Yehuda integrates immunology and cutting-edge gene therapy for blood diseases.

• Professor with 34 years of experience in hematology and immunology
• Pioneer in bone marrow transplants and gene therapy
• Trained at Memorial Sloan-Kettering Cancer Center in New York
• First female Dean of Hadassah School of Medicine
• Recipient of multiple prestigious awards for patient care

Dr. Dimitrios Karussis leads the multi-disciplinary Multiple Sclerosis Clinic at Hadassah Medical Center with 40 years of experience in neuroimmunology.

• Specializes in neuroimmunology and bone marrow transplantation
• Head of the EAE Laboratory at Hadassah
• Member of the European 'Steering Committee' for Bone Marrow Transplantation
• PhD in Neuroimmunology/Neurobiology

Dr. Michael Lotem leads the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center, pioneering new treatments for melanoma.

• Specializes in immunotherapy for cancer treatment
• Studies SLAM receptors in anti-cancer immune responses
• Combines clinical practice with translational research
• Team includes top clinicians and researchers

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.